Skip to content

New Harbor Capital Portfolio Company Wedgewood Pharmacy Completes Merger

New Harbor Capital branded teal private equity investments icon private equity news

Two of the nation’s most trusted animal health compounding pharmacies, Wedgewood Pharmacy (Swedesboro, New Jersey) and Diamondback Drugs (Scottsdale, Arizona), have merged to form the largest compounding pharmacy in the United States.

The combined company will operate as Wedgewood Pharmacy, with more than 500 employees serving 40,000 prescribers and hundreds of thousands of animal owners from two geographically strategic facilities.  Wedgewood will have the most comprehensive portfolio of formulations available and industry-leading technology, to better help them care for the unique needs of their animals.  The integration of the two companies will improve the speed of delivery to veterinary practices and patients and will set the benchmark for the service and quality available to the market today.  For additional information, please visit and

The combined organization will be led by Marcy A. Bliss, Wedgewood Pharmacy’s President and CEO. Bliss said, “Combining our two pharmacies will provide more capabilities and enhanced service for all of our customers. Our deep, combined expertise in compounding medications, together with best-practice prescribing tools and technology, will facilitate an exceptional customer experience and veterinary healthcare.”

Maranon Capital was the agent in providing debt financing for the transaction and ReedSmith LLP served as legal counsel to Wedgewood.